世界の白血病治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Leukemia Therapeutic Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3403 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、白血病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（誘導療法、強化療法、維持療法）、用途別市場規模（がん研究センター、診断研究所、クリニック、病院）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・白血病治療の市場動向 ・企業の競争状況、市場シェア ・白血病治療の種類別市場規模（誘導療法、強化療法、維持療法） ・白血病治療の用途別市場規模（がん研究センター、診断研究所、クリニック、病院） ・白血病治療の北米市場規模2016-2027（アメリカ、カナダ） ・白血病治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・白血病治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・白血病治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・白血病治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Genzyme、Novartis International、Pfizer、Roche Holding、Celgene Corporation、Ariad Pharmaceuticals、Clavis Pharma、Sunesis Pharmaceuticals） ・結論

Leukemia is a type of cancer which is formed in blood tissues. Leukemia occurs in bone marrow which is a soft tissue. Leukemia develops by the uncontrolled growth of blood cells in the bone marrow. Leukemia is also defined as a cancer of white blood cells. Leukemia therapeutics consists of three steps including induction therapy, consolidation therapy and maintenance therapy.
In recent time there is increased use of leukemia therapeutic due to rising number of cancer diseases across the world. Rising aging population, lifestyle factors and increasing awareness for healthcare are some of the key driving factors for the growth of the global leukemia therapeutics market. In addition, innovative and targeted drug delivery is also fuelling the growth of the global leukemia therapeutics market. However, availability of large numbers of generic form of drugs and limited treatment options are some of the major factors restraining the growth of the global leukemia therapeutics market. In addition, high unmet need for diagnosis is also restraining the growth of the global leukemia therapeutics market.

Market Analysis and Insights: Global Leukemia Therapeutic Market
The global Leukemia Therapeutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Leukemia Therapeutic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Leukemia Therapeutic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Leukemia Therapeutic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Leukemia Therapeutic market.

Global Leukemia Therapeutic Scope and Market Size
Leukemia Therapeutic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Leukemia Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Induction Therapy
Consolidation Therapy
Maintenance Therapy

Segment by Application
Cancer Research Centers
Diagnostic Laboratories
Clinics
Hospitals

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Genzyme
Novartis International
Pfizer
Roche Holding
Celgene Corporation
Ariad Pharmaceuticals
Clavis Pharma
Sunesis Pharmaceuticals

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Leukemia Therapeutic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Induction Therapy
1.2.3 Consolidation Therapy
1.2.4 Maintenance Therapy
1.3 Market by Application
1.3.1 Global Leukemia Therapeutic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer Research Centers
1.3.3 Diagnostic Laboratories
1.3.4 Clinics
1.3.5 Hospitals
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Leukemia Therapeutic Market Perspective (2016-2027)
2.2 Leukemia Therapeutic Growth Trends by Regions
2.2.1 Leukemia Therapeutic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Leukemia Therapeutic Historic Market Share by Regions (2016-2021)
2.2.3 Leukemia Therapeutic Forecasted Market Size by Regions (2022-2027)
2.3 Leukemia Therapeutic Industry Dynamic
2.3.1 Leukemia Therapeutic Market Trends
2.3.2 Leukemia Therapeutic Market Drivers
2.3.3 Leukemia Therapeutic Market Challenges
2.3.4 Leukemia Therapeutic Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Leukemia Therapeutic Players by Revenue
3.1.1 Global Top Leukemia Therapeutic Players by Revenue (2016-2021)
3.1.2 Global Leukemia Therapeutic Revenue Market Share by Players (2016-2021)
3.2 Global Leukemia Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Leukemia Therapeutic Revenue
3.4 Global Leukemia Therapeutic Market Concentration Ratio
3.4.1 Global Leukemia Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Leukemia Therapeutic Revenue in 2020
3.5 Leukemia Therapeutic Key Players Head office and Area Served
3.6 Key Players Leukemia Therapeutic Product Solution and Service
3.7 Date of Enter into Leukemia Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Leukemia Therapeutic Breakdown Data by Type
4.1 Global Leukemia Therapeutic Historic Market Size by Type (2016-2021)
4.2 Global Leukemia Therapeutic Forecasted Market Size by Type (2022-2027)

5 Leukemia Therapeutic Breakdown Data by Application
5.1 Global Leukemia Therapeutic Historic Market Size by Application (2016-2021)
5.2 Global Leukemia Therapeutic Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Leukemia Therapeutic Market Size (2016-2027)
6.2 North America Leukemia Therapeutic Market Size by Type
6.2.1 North America Leukemia Therapeutic Market Size by Type (2016-2021)
6.2.2 North America Leukemia Therapeutic Market Size by Type (2022-2027)
6.2.3 North America Leukemia Therapeutic Market Size by Type (2016-2027)
6.3 North America Leukemia Therapeutic Market Size by Application
6.3.1 North America Leukemia Therapeutic Market Size by Application (2016-2021)
6.3.2 North America Leukemia Therapeutic Market Size by Application (2022-2027)
6.3.3 North America Leukemia Therapeutic Market Size by Application (2016-2027)
6.4 North America Leukemia Therapeutic Market Size by Country
6.4.1 North America Leukemia Therapeutic Market Size by Country (2016-2021)
6.4.2 North America Leukemia Therapeutic Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Leukemia Therapeutic Market Size (2016-2027)
7.2 Europe Leukemia Therapeutic Market Size by Type
7.2.1 Europe Leukemia Therapeutic Market Size by Type (2016-2021)
7.2.2 Europe Leukemia Therapeutic Market Size by Type (2022-2027)
7.2.3 Europe Leukemia Therapeutic Market Size by Type (2016-2027)
7.3 Europe Leukemia Therapeutic Market Size by Application
7.3.1 Europe Leukemia Therapeutic Market Size by Application (2016-2021)
7.3.2 Europe Leukemia Therapeutic Market Size by Application (2022-2027)
7.3.3 Europe Leukemia Therapeutic Market Size by Application (2016-2027)
7.4 Europe Leukemia Therapeutic Market Size by Country
7.4.1 Europe Leukemia Therapeutic Market Size by Country (2016-2021)
7.4.2 Europe Leukemia Therapeutic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Leukemia Therapeutic Market Size (2016-2027)
8.2 Asia-Pacific Leukemia Therapeutic Market Size by Type
8.2.1 Asia-Pacific Leukemia Therapeutic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Leukemia Therapeutic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Leukemia Therapeutic Market Size by Type (2016-2027)
8.3 Asia-Pacific Leukemia Therapeutic Market Size by Application
8.3.1 Asia-Pacific Leukemia Therapeutic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Leukemia Therapeutic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Leukemia Therapeutic Market Size by Application (2016-2027)
8.4 Asia-Pacific Leukemia Therapeutic Market Size by Region
8.4.1 Asia-Pacific Leukemia Therapeutic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Leukemia Therapeutic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Leukemia Therapeutic Market Size (2016-2027)
9.2 Latin America Leukemia Therapeutic Market Size by Type
9.2.1 Latin America Leukemia Therapeutic Market Size by Type (2016-2021)
9.2.2 Latin America Leukemia Therapeutic Market Size by Type (2022-2027)
9.2.3 Latin America Leukemia Therapeutic Market Size by Type (2016-2027)
9.3 Latin America Leukemia Therapeutic Market Size by Application
9.3.1 Latin America Leukemia Therapeutic Market Size by Application (2016-2021)
9.3.2 Latin America Leukemia Therapeutic Market Size by Application (2022-2027)
9.3.3 Latin America Leukemia Therapeutic Market Size by Application (2016-2027)
9.4 Latin America Leukemia Therapeutic Market Size by Country
9.4.1 Latin America Leukemia Therapeutic Market Size by Country (2016-2021)
9.4.2 Latin America Leukemia Therapeutic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Leukemia Therapeutic Market Size (2016-2027)
10.2 Middle East & Africa Leukemia Therapeutic Market Size by Type
10.2.1 Middle East & Africa Leukemia Therapeutic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Leukemia Therapeutic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Leukemia Therapeutic Market Size by Type (2016-2027)
10.3 Middle East & Africa Leukemia Therapeutic Market Size by Application
10.3.1 Middle East & Africa Leukemia Therapeutic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Leukemia Therapeutic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Leukemia Therapeutic Market Size by Application (2016-2027)
10.4 Middle East & Africa Leukemia Therapeutic Market Size by Country
10.4.1 Middle East & Africa Leukemia Therapeutic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Leukemia Therapeutic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Genzyme
11.1.1 Genzyme Company Details
11.1.2 Genzyme Business Overview
11.1.3 Genzyme Leukemia Therapeutic Introduction
11.1.4 Genzyme Revenue in Leukemia Therapeutic Business (2016-2021)
11.1.5 Genzyme Recent Development
11.2 Novartis International
11.2.1 Novartis International Company Details
11.2.2 Novartis International Business Overview
11.2.3 Novartis International Leukemia Therapeutic Introduction
11.2.4 Novartis International Revenue in Leukemia Therapeutic Business (2016-2021)
11.2.5 Novartis International Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Leukemia Therapeutic Introduction
11.3.4 Pfizer Revenue in Leukemia Therapeutic Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Roche Holding
11.4.1 Roche Holding Company Details
11.4.2 Roche Holding Business Overview
11.4.3 Roche Holding Leukemia Therapeutic Introduction
11.4.4 Roche Holding Revenue in Leukemia Therapeutic Business (2016-2021)
11.4.5 Roche Holding Recent Development
11.5 Celgene Corporation
11.5.1 Celgene Corporation Company Details
11.5.2 Celgene Corporation Business Overview
11.5.3 Celgene Corporation Leukemia Therapeutic Introduction
11.5.4 Celgene Corporation Revenue in Leukemia Therapeutic Business (2016-2021)
11.5.5 Celgene Corporation Recent Development
11.6 Ariad Pharmaceuticals
11.6.1 Ariad Pharmaceuticals Company Details
11.6.2 Ariad Pharmaceuticals Business Overview
11.6.3 Ariad Pharmaceuticals Leukemia Therapeutic Introduction
11.6.4 Ariad Pharmaceuticals Revenue in Leukemia Therapeutic Business (2016-2021)
11.6.5 Ariad Pharmaceuticals Recent Development
11.7 Clavis Pharma
11.7.1 Clavis Pharma Company Details
11.7.2 Clavis Pharma Business Overview
11.7.3 Clavis Pharma Leukemia Therapeutic Introduction
11.7.4 Clavis Pharma Revenue in Leukemia Therapeutic Business (2016-2021)
11.7.5 Clavis Pharma Recent Development
11.8 Sunesis Pharmaceuticals
11.8.1 Sunesis Pharmaceuticals Company Details
11.8.2 Sunesis Pharmaceuticals Business Overview
11.8.3 Sunesis Pharmaceuticals Leukemia Therapeutic Introduction
11.8.4 Sunesis Pharmaceuticals Revenue in Leukemia Therapeutic Business (2016-2021)
11.8.5 Sunesis Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Leukemia Therapeutic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Induction Therapy
Table 3. Key Players of Consolidation Therapy
Table 4. Key Players of Maintenance Therapy
Table 5. Global Leukemia Therapeutic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Leukemia Therapeutic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Leukemia Therapeutic Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Leukemia Therapeutic Market Share by Regions (2016-2021)
Table 9. Global Leukemia Therapeutic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Leukemia Therapeutic Market Share by Regions (2022-2027)
Table 11. Leukemia Therapeutic Market Trends
Table 12. Leukemia Therapeutic Market Drivers
Table 13. Leukemia Therapeutic Market Challenges
Table 14. Leukemia Therapeutic Market Restraints
Table 15. Global Leukemia Therapeutic Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Leukemia Therapeutic Market Share by Players (2016-2021)
Table 17. Global Top Leukemia Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leukemia Therapeutic as of 2020)
Table 18. Ranking of Global Top Leukemia Therapeutic Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Leukemia Therapeutic Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Leukemia Therapeutic Product Solution and Service
Table 22. Date of Enter into Leukemia Therapeutic Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Leukemia Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Leukemia Therapeutic Revenue Market Share by Type (2016-2021)
Table 26. Global Leukemia Therapeutic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Leukemia Therapeutic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Leukemia Therapeutic Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Leukemia Therapeutic Revenue Market Share by Application (2016-2021)
Table 30. Global Leukemia Therapeutic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Leukemia Therapeutic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Leukemia Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Leukemia Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Leukemia Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Leukemia Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Leukemia Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Leukemia Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Leukemia Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Leukemia Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Leukemia Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Leukemia Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Leukemia Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Leukemia Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Leukemia Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Leukemia Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Leukemia Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Leukemia Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Leukemia Therapeutic Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Leukemia Therapeutic Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Leukemia Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Leukemia Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Leukemia Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Leukemia Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Leukemia Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Leukemia Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Leukemia Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Leukemia Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Leukemia Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Leukemia Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Leukemia Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Leukemia Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 62. Genzyme Company Details
Table 63. Genzyme Business Overview
Table 64. Genzyme Leukemia Therapeutic Product
Table 65. Genzyme Revenue in Leukemia Therapeutic Business (2016-2021) & (US$ Million)
Table 66. Genzyme Recent Development
Table 67. Novartis International Company Details
Table 68. Novartis International Business Overview
Table 69. Novartis International Leukemia Therapeutic Product
Table 70. Novartis International Revenue in Leukemia Therapeutic Business (2016-2021) & (US$ Million)
Table 71. Novartis International Recent Development
Table 72. Pfizer Company Details
Table 73. Pfizer Business Overview
Table 74. Pfizer Leukemia Therapeutic Product
Table 75. Pfizer Revenue in Leukemia Therapeutic Business (2016-2021) & (US$ Million)
Table 76. Pfizer Recent Development
Table 77. Roche Holding Company Details
Table 78. Roche Holding Business Overview
Table 79. Roche Holding Leukemia Therapeutic Product
Table 80. Roche Holding Revenue in Leukemia Therapeutic Business (2016-2021) & (US$ Million)
Table 81. Roche Holding Recent Development
Table 82. Celgene Corporation Company Details
Table 83. Celgene Corporation Business Overview
Table 84. Celgene Corporation Leukemia Therapeutic Product
Table 85. Celgene Corporation Revenue in Leukemia Therapeutic Business (2016-2021) & (US$ Million)
Table 86. Celgene Corporation Recent Development
Table 87. Ariad Pharmaceuticals Company Details
Table 88. Ariad Pharmaceuticals Business Overview
Table 89. Ariad Pharmaceuticals Leukemia Therapeutic Product
Table 90. Ariad Pharmaceuticals Revenue in Leukemia Therapeutic Business (2016-2021) & (US$ Million)
Table 91. Ariad Pharmaceuticals Recent Development
Table 92. Clavis Pharma Company Details
Table 93. Clavis Pharma Business Overview
Table 94. Clavis Pharma Leukemia Therapeutic Product
Table 95. Clavis Pharma Revenue in Leukemia Therapeutic Business (2016-2021) & (US$ Million)
Table 96. Clavis Pharma Recent Development
Table 97. Sunesis Pharmaceuticals Company Details
Table 98. Sunesis Pharmaceuticals Business Overview
Table 99. Sunesis Pharmaceuticals Revenue in Leukemia Therapeutic Business (2016-2021) & (US$ Million)
Table 100. Sunesis Pharmaceuticals Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Leukemia Therapeutic Market Share by Type: 2020 VS 2027
Figure 2. Induction Therapy Features
Figure 3. Consolidation Therapy Features
Figure 4. Maintenance Therapy Features
Figure 5. Global Leukemia Therapeutic Market Share by Application: 2020 VS 2027
Figure 6. Cancer Research Centers Case Studies
Figure 7. Diagnostic Laboratories Case Studies
Figure 8. Clinics Case Studies
Figure 9. Hospitals Case Studies
Figure 10. Leukemia Therapeutic Report Years Considered
Figure 11. Global Leukemia Therapeutic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Leukemia Therapeutic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Leukemia Therapeutic Market Share by Regions: 2020 VS 2027
Figure 14. Global Leukemia Therapeutic Market Share by Regions (2022-2027)
Figure 15. Global Leukemia Therapeutic Market Share by Players in 2020
Figure 16. Global Top Leukemia Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leukemia Therapeutic as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Leukemia Therapeutic Revenue in 2020
Figure 18. Global Leukemia Therapeutic Revenue Market Share by Type (2016-2021)
Figure 19. Global Leukemia Therapeutic Revenue Market Share by Type (2022-2027)
Figure 20. North America Leukemia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Leukemia Therapeutic Market Share by Type (2016-2027)
Figure 22. North America Leukemia Therapeutic Market Share by Application (2016-2027)
Figure 23. North America Leukemia Therapeutic Market Share by Country (2016-2027)
Figure 24. United States Leukemia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Leukemia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Leukemia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Leukemia Therapeutic Market Share by Type (2016-2027)
Figure 28. Europe Leukemia Therapeutic Market Share by Application (2016-2027)
Figure 29. Europe Leukemia Therapeutic Market Share by Country (2016-2027)
Figure 30. Germany Leukemia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Leukemia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Leukemia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Leukemia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Leukemia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Leukemia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Leukemia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Leukemia Therapeutic Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Leukemia Therapeutic Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Leukemia Therapeutic Market Share by Region (2016-2027)
Figure 40. China Leukemia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Leukemia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Leukemia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Leukemia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Leukemia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Leukemia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Leukemia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Leukemia Therapeutic Market Share by Type (2016-2027)
Figure 48. Latin America Leukemia Therapeutic Market Share by Application (2016-2027)
Figure 49. Latin America Leukemia Therapeutic Market Share by Country (2016-2027)
Figure 50. Mexico Leukemia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Leukemia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Leukemia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Leukemia Therapeutic Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Leukemia Therapeutic Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Leukemia Therapeutic Market Share by Country (2016-2027)
Figure 56. Turkey Leukemia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Leukemia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Leukemia Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Genzyme Revenue Growth Rate in Leukemia Therapeutic Business (2016-2021)
Figure 60. Novartis International Revenue Growth Rate in Leukemia Therapeutic Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Leukemia Therapeutic Business (2016-2021)
Figure 62. Roche Holding Revenue Growth Rate in Leukemia Therapeutic Business (2016-2021)
Figure 63. Celgene Corporation Revenue Growth Rate in Leukemia Therapeutic Business (2016-2021)
Figure 64. Ariad Pharmaceuticals Revenue Growth Rate in Leukemia Therapeutic Business (2016-2021)
Figure 65. Clavis Pharma Revenue Growth Rate in Leukemia Therapeutic Business (2016-2021)
Figure 66. Sunesis Pharmaceuticals Revenue Growth Rate in Leukemia Therapeutic Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---